FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069164 [Registered on: 19/06/2024] Trial Registered Prospectively
Last Modified On: 17/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Management of Cutaneous Warts with Homoeopathic medicines 
Scientific Title of Study   A Clinical study on Management of Cutaneous Warts with Homoeopathic Medicines in 50 Millesimal Potencies 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Preethi James P  
Designation  Pg Scholar  
Affiliation  DR MGR Medical University Chennai ,White Memorial Homoeo Medical College and Hospital  
Address  Department of Materia Medica White Memorial Homoeo Medical College and Hospital Attoor, Veeyannoor PO Kanniyakumari Tamilnadu Tamilnadu - 629177

Kanniyakumari
TAMIL NADU
629177
India 
Phone  7708626518  
Fax    
Email  preethijamesp22@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prasobh M P 
Designation  Associate Professor  
Affiliation  White Memorial Homoeo Medical College and Hospital  
Address  Department of Materia Medica White Memorial Homoeo Medical College and Hospital Attoor, Veeyannoor PO Kanniyakumari Tamilnadu - 629177

Kanniyakumari
TAMIL NADU
629177
India 
Phone  9447746688  
Fax    
Email  drprasobhmp@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Preethi James P  
Designation  Pg Scholar  
Affiliation  White Memorial Homoeo Medical College and Hospital  
Address  Department of Materia Medica White Memorial Homoeo Medical College and Hospital Attoor, Veeyannoor PO Kanniyakumari Tamilnadu -629177

Kanniyakumari
TAMIL NADU
629177
India 
Phone  7708626518  
Fax    
Email  preethijamesp22@gmail.com  
 
Source of Monetary or Material Support  
Department of Materia Medica White Memorial Homoeo Medical College and Hospital Attoor,Veeyannoor PO kanniyakumari Tamilnadu 629117 
 
Primary Sponsor  
Name  White Memorial Homoeo medical College and hospital  
Address  White Memorial Homoeo medical College and hospital, Attoor, Veeyannoor PO, kanniyakumari Tamilnadu 629177 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Preethi James P   White Memorial Homoeo Medical College and hospital   Department of Materia Medica White Memorial Homoeo medical College and hospital, Attoor, Veeyannoor PO Veeyannoor Kanniyakumari Tamilnadu
Kanniyakumari
TAMIL NADU 
7708626518

preethijamesp22@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee White Memorial Homoeo Medical College and Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B079||Viral wart, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homeopathic medicines in 50 millesimal potencies  Individualized Homeopathic medicines in 50 millesimal potencies will be administered to the patient in proper dose, potency and repitation of medicine according to Homeopathic principles.All the individuals in the study are given medicine. Each case will be reviewed after 15 days interval or as per need in case of emergency and followed up for maximum of 6 months.Assessment of the case will be done using Cutaneous warts Diagnostic tool at the last. 
Comparator Agent  Not Applicable   Not Applicable  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients who are diagnosed with cutaneous warts.
Subject of both sexes.
Age group from 18 to 60 years 
 
ExclusionCriteria 
Details  Patient with Ano genital warts.
Pregnant and lactating wonen.
Individuals already under treatment (Medicinal/surgical/both) within 1 month for cutaneous warts.
Immunocompromised patients.
Case with HIV and Cancerous manifestation.  
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Reducing the size of warts.  After 15 days 
 
Secondary Outcome  
Outcome  TimePoints 
After completion of study follow up & assessment of size of warts will be done  Maximum of 6 months  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A minimum of 50 cases will be selected for the study by purposive sampling.
Cases will be taken in detail and recorded in the structured case sheet formulated for the study.
Diagnosis will be done by clinical presentation and examination.
Assessment is done using Cutaneous wart diagnostic tool.
In each case, medicines will be selected after taking the detailed case history and performing analysis, evaluation, and repertorization. Medicines are differentiated using various Materia medica.
A single homoeopathic medicine in 50 millesimal potency is prescribed as per the law ofhomeopathy.
Follow up will be done once in 15 days and further treatment was proceed accordingly based on existing symptoms.
Results will be assessed by pre and post 
 
Close